Preview Mode Links will not work in preview mode

May 19, 2021

Featuring an interview with Dr Adam M Brufsky, including the following topics:

  • Personalized medicine for HER2-positive early breast cancer (0:00)
  • Case: A woman in her early 60s with ER/PR-positive, HER2-positive invasive ductal carcinoma who receives T-DM1 and neratinib (21:40)
  • Case: A woman in her mid-40s with ER/PR-positive, HER2-positive early breast cancer (23:48)
  • Case: A woman in her late 50s with ER/PR-negative, HER2-positive early breast cancer (26:10)

CME information and select publications